EMG
ITCI

ETF Managers Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

ETF Managers Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,713
Closed -$276K – 585
2019
Q2 		$276K Sell
21,713
-4,104
-16% -$52.6K 0.01% 294
2019
Q1 		$314K Sell
25,817
-2,280
-8% -$29.1K 0.02% 258
2018
Q4 		$320K Sell
28,097
-3,990
-12% -$64.4K 0.02% 261
2018
Q3 		$696K Buy
32,087
+8,208
+34% +$172K 0.03% 202
2018
Q2 		$2.13M Buy
23,879
+114
+0.5% +$2.31K 0.15% 82
2018
Q1 		$460K Buy
+23,765
New +$463K 0.03% 215

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETF Managers Group's ITCI Position: Q3 2019 in Review

ETF Managers Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2019, closing a stake of 21,713 shares — an estimated $276K sold.

ETF Managers Group first reported a position in ITCI in Q1 2018 and held it in 6 quarters. The position peaked at $2.13M in Q2 2018. 126 funds tracked by Wall St. Rank hold ITCI as of Q3 2019.

  • ETF Managers Group reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2019 after selling out during the quarter.
  • ETF Managers Group sold 21,713 Intra-Cellular Therapies Inc. shares in Q3 2019, an estimated $276K.
  • ETF Managers Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2018 and held it in 6 quarters.
  • ETF Managers Group's Intra-Cellular Therapies Inc. position peaked at $2.13M in Q2 2018.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2019.

Based on ETF Managers Group's 13F filing for Q3 2019, filed 14 Nov 2019.